INS and Wolfram syndrome: On the other hand, in dulaglutide-treated mice gliclazide and KCl, but not high glucose, stimulated insulin secretion, showing that GLP-1R agonists increase at least in part the function of beta cells from individuals affected by Wolfram syndrome (Fig. 6h).